Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.
#439 most reported symptom for this vaccine
Respiratory rate increased has been reported 61 times in association with Measles, Mumps & Rubella (MMR II) vaccination in VAERS. This represents 0.1% of all 89,976 reports for this vaccine.
Among these reports, 0 mentioned death (0.00%) and 11 involved hospitalization (18.0%).
Respiratory rate increased is the #439 most frequently reported symptom for Measles, Mumps & Rubella (MMR II) out of 2292 total symptoms.
Disclaimer: VAERS reports describe events that occurred after vaccination but do not establish that the vaccine caused the event. Many reported symptoms may be coincidental or related to underlying conditions.
Seeing 61 reports of Respiratory rate increased after Measles, Mumps & Rubella (MMR II) vaccination may seem alarming, but context is critical.
The mortality rate among these reports is very low at 0.00%, suggesting most cases are non-fatal.
This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.